source
- TScan Therapeutics slashes 75% of staff as it pivots to solid tumor programTScan Therapeutics announced on Sept. 2 that it is cutting roughly 75% of its workforce, about 104 employees, as part of a strategic reorganization. The move follows a November 2025 layoff that el…
- ARPA-H allocates up to $125 million to accelerate personalized RNA therapy manufacturingARPA-H announced a new program, called GIVE, that will provide up to $125 million in research funding to develop faster, decentralized manufacturing methods for individualized RNA‑based genetic med…